Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.

Selected Research

Statin Use Before and After an Ischemic Event Has Better Outcomes
Medscape, 4-13-05

Researchers here present data showing that patients “who are treated with a drug in the statin class either before or shortly after an ischemic stroke are more likely to survive and go home on discharge rather than die or be transferred to an extended care facility.”

"These findings represent an important step in a growing pool of knowledge showing that statins reduce the risk of recurrent stroke and improve outcomes," said Mark J. Alberts, MD, in an interview seeking outside comment. "The study has limitations in that it is a retrospective, registry study, which means that it is susceptible to several biases, such as selection bias." Dr. Alberts is a professor of neurology at Northwestern University Feinberg School of Medicine in Chicago, Illinois, where he is director of the stroke program.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000